NeueHealth
NEUE
NEUE was delisted on the 1st of October, 2025.
117 hedge funds and large institutions have $1.37B invested in NeueHealth in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 27 closing their positions.
386% more call options, than puts
Call options by funds: $10.5M | Put options by funds: $2.16M
180% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 15
70% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 27
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
15% more funds holding
Funds holding: 102 → 117 (+15)
0.09% more ownership
Funds ownership: 0.81% → 0.9% (+0.09%)
58% less capital invested
Capital invested by funds: $3.29B → $1.37B (-$1.91B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LWAM
Legacy Wealth Asset Management
Woodbury,
Minnesota
|
+$36.6M |
| 2 |
Blackstone Inc
New York
|
+$31.8M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$20.1M |
| 4 |
E
Ergoteles
New York
|
+$8.48M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$8.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$122M |
| 2 |
Tiger Global Management
New York
|
-$49M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$15.7M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$14.4M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$12.2M |
NEUE Hedge Fund Activity: Q4 2021 in Review
117 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q4 2021, worth a combined $1.37B — down 58% from $3.29B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new NEUE positions and 27 closed out — a net gain of 19 holders — while 42 added to existing stakes and 15 trimmed.
The largest buyer was Legacy Wealth Asset Management, opening a new position worth an estimated $36.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $122M.
- 117 institutional investors held NeueHealth (NEUE) as of Q4 2021, up from 102 in Q3 2021.
- Funds reported $1.37B of NeueHealth stock for Q4 2021, down 58% quarter-over-quarter.
- 46 funds opened new NeueHealth positions in Q4 2021 and 27 closed out, a net change of +19 holders.
- The largest NeueHealth buyer in Q4 2021 was Legacy Wealth Asset Management, an estimated $36.6M added.
- The largest NeueHealth seller in Q4 2021 was T. Rowe Price Associates, an estimated $122M sold.
Based on aggregated 13F filings for Q4 2021.